| Cancer |
Tissue Repository For The Collection of Hematologic Samples |
Suzanne Lentzsch, MD |
| Cancer |
Collecting and growing patient tumor and blood cells from extra tissue to learn about cancer and test new drugs |
Bret Taback, MD |
| Cancer |
Identification of Targets for Cancer Treatment |
Andrea Califano, PhD |
| Cancer |
Early Onset Malignancies Initiative (EOMI) |
Bret Taback, MD |
| Cancer |
Study of Atezolizumab in Alveolar Soft Part Sarcoma |
Prabhjot Mundi, MD |
| Cancer |
Study of Drug in Patients with Advanced Solid Malignancies and Lymphoma |
June Hou, MD |
| Cancer |
Clinical Trial Screening Tool to Address Cancer Health Disparities |
Katherine Crew, MD |
| Cancer |
A Study of MS-553 in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) |
Nicole Lamanna, MD |
| Cancer |
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) |
Antonio Fojo, MD, PhD |
| Cancer |
Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) |
Mark Stein, MD |
| Cancer |
Study of IDE196 in Patients with Solid Tumors |
Shaheer Khan, DO |
| Cancer |
Study of A Vaccine Targeting Shared Neoantigens in Subjects with Advanced Solid Tumors |
Brian Henick, MD |
| Cancer |
Study of AMG510 in Subjects with Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) |
Brian Henick, MD |
| Cancer |
Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia |
Ran Reshef, MD |
| Cancer |
TCR-engineered T Cells in Solid Tumors (ACTengine) |
Ran Reshef, MD |
| Cancer |
A Study of MORAb-202 in Participants With Selected Tumor Types |
June Hou, MD |
| Cancer |
Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors |
Catherine Shu, MD |
| Cancer |
Study of ST101 in Patients with Advanced Solid Tumors |
Fabio Iwamoto, MD |
| Cancer |
Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers |
Benjamin Izar, MD |
| Cancer |
A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors |
Matthew Ingham, MD |
| Cancer |
A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors |
Shaheer Khan, DO |
| Cancer |
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer |
Brian Henick, MD |
| Cancer |
Study of AB928 in Combination with Other Therapies for Patients with Metastatic Colon Cancer (mCRC) |
Gulam Manji, MD, PhD |
| Cancer |
Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer |
Ryan Moy, MD |
| Cancer |
Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer |
Mark Stein, MD |
| Cancer |
Study of IV Contrast on Patients Going Through Image Guided Radiation Therapy (IGRT) for Abdominal and Pelvic Cancer |
David Horowitz, MD |
| Cancer |
Study of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) |
Divaya Bhutani, MD |
| Cancer |
Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer |
Benjamin Herzberg, MD |
| Cancer |
Study of IDE397 in Patients with Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of CS5001 in Patients with Advanced Solid Tumors |
Shaheer Khan, DO |
| Cancer |
Study of RP-6306 in Combination with FOLFIRI in Patients with Advanced Solid Tumors (Colon, Esophageal, or GI Cancer) |
Ryan Moy, MD |
| Cancer |
ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma |
Ran Reshef, MD |
| Cancer |
Study of BT7480 in Patients with Advanced Cancer |
Mark Stein, MD |
| Cancer |
Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation |
Benjamin Herzberg, MD |
| Cancer |
Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors |
Benjamin Izar, MD |
| Cancer |
Study of ISIS 702843 in Patients with Phlebotomy-Dependent Polycythemia Vera (PD-PV) |
Joseph Jurcic, MD |
| Cancer |
Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer |
Ryan Moy, MD |
| Cancer |
Study of E-602 Alone or in Combination with Libtayo (Cemiplimab) in Patients with Advanced Cancer |
Brian Henick, MD |
| Cancer |
Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer |
Brian Henick, MD |
| Cancer |
Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer |
Brian Henick, MD |
| Cancer |
Study of RMC-6291 in Patients with Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of Gavo-Cel Alone or in Combination with Nivolumab or Ipilimumab in Patients with Advanced Cancer |
Ran Reshef, MD |
| Cancer |
Study of ASKG915 in Patients with Advanced Solid Tumors |
Mark Stein, MD |
| Cancer |
Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors |
Karie D. Runcie, MD |
| Cancer |
Study of MRT-2359 in Patients with Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation |
Benjamin Herzberg, MD |
| Cancer |
Study of BGB-16673 in Patients with Leukemia or Lymphoma |
Nicole Lamanna, MD |
| Breast Cancer |
Study to Predict Your Therapeutic Response (I-SPY 2 Trial) |
Meghna Trivedi, MD |
| Breast Cancer |
Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer |
Melissa Accordino, MD |
| Breast Cancer |
Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients |
Dawn Hershman, MD |
| Breast Cancer |
MiChoice: Making Informed Choices on Incorporating Chemoprevention Into Care |
Katherine Crew, MD |
| Breast Cancer |
Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors |
Dawn Hershman, MD |
| Breast Cancer |
Study of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple-Negative Breast Cancer |
Meghna Trivedi, MD |
| Breast Cancer |
Decreasing Chemotherapy for HER2 Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy |
Julia McGuinness, MD |
| Breast Cancer |
Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Intervention to Improve Medication Scheduling for Patients with Breast Cancer |
Dawn Hershman, MD |
| Breast Cancer |
Study of RLY-2608 in Patients with Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Study of Radiation Therapy Alone or in Combination With Olaparib for Patients with Inflammatory Breast Cancer (IBC) |
Eileen Connolly, MD, PhD |
| Breast Cancer |
Study of GLSI-100 in Female Patients with Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation |
Katherine Crew, MD |
| Breast Cancer |
Study of Drug - LY3484356 in Patients with Breast Cancer (ER+, HER2-) |
Meghna Trivedi, MD |
| Breast Cancer |
Study of Sacituzumab Govitecan (TRODELVY) in Patients with Triple-Negative Breast Cancer (TNBC) |
Meghna Trivedi, MD |
| Breast Cancer |
Study of Sacituzumab Govitecan in Combination with Pembrolizumab vs. Chemotherapy in Patients with Advanced Triple-Negative Breast Cancer |
Meghna Trivedi, MD |
| Breast Cancer |
Study of Breast Cancer in Black Women |
Lauren Houghton, PhD |
| Breast Cancer |
Study of Breast Cancer in Black Women - Healthy Controls |
Lauren Houghton, PhD |
| Breast Cancer |
Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer |
John Markowitz, MD |
| Multiple Myeloma |
Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma (KarMMa-2) |
Ran Reshef, MD |
| Multiple Myeloma |
First in Human (FIH) Study of REGN5458 in Patients With Relapsed or Refractory Multiple Myeloma |
Suzanne Lentzsch, MD |
| Multiple Myeloma |
Safety and Efficacy of Bb2121 (Ide-cel) Combinations in Patients with Multiple Myeloma (KarMMa-7) |
Ran Reshef, MD |
| Multiple Myeloma |
Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant |
Divaya Bhutani, MD |
| Multiple Myeloma |
Study of Daratumumab in Addition to Chemotherapy for Patients with Smoldering Multiple Myeloma (SMM) |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of VRd Followed by Cilta-cel vs. VRd Followed by Rd Therapy in Patients with Newly Diagnosed Multiple Myeloma |
Ran Reshef, MD |
| Multiple Myeloma |
Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of STI-6129 in Patients with Relapse/Refractory Multiple Myeloma (RRMM) |
Rajshekhar Chakraborty, MD |
| Skin Cancer |
Study of RP1 in Organ Transplant Patients with Skin Cancer |
Shaheer Khan, DO |
| Liver Cancer |
A 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer) |
Elizabeth Verna, MD |
| Lymphoma |
Study of Drug for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease |
Ran Reshef, MD |
| Lymphoma |
Study of Tazemetostat or Placebo with Lenalidomide plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma |
Jennifer Amengual, MD |
| Lymphoma |
Study of LOXO-305 in Patients with Mantle Cell Lymphoma (MCL) |
Andrew Lipsky, MD |
| Lymphoma |
Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant |
Divaya Bhutani, MD |
| Lymphoma |
Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) |
Jennifer Amengual, MD |
| Lymphoma |
Study of TAK-007 in Patients with Non-Hodgkin Lymphoma |
Ran Reshef, MD |
| Lymphoma |
Study of Duvelisib or Azacitidine in Addition to Chemotherapy in Patients with Peripheral T-Cell Lymphoma (PTCL) |
Jennifer Amengual, MD |
| Lymphoma |
Study of Lenalidomide in Combination with Chemotherapy in Patients with HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL) |
Jennifer Amengual, MD |
| Lymphoma |
Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Follicular Lymphoma |
Ran Reshef, MD |
| Lymphoma |
Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia |
Ran Reshef, MD |
| Lymphoma |
Study of Tazemetostat in Combination with Belinostat in Patients with Relapsed or Refractory Lymphoma |
Jennifer Amengual, MD |
| Lymphoma |
Study of ONO-4685 in Patients with T-Cell Lymphoma |
Barbara Pro, MD |
| Lymphoma |
Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma |
Ran Reshef, MD |
| Lung Cancer |
Study of Therapies in Participants with Resectable (removable) and Untreated Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Testing Whether the Use of Brain Scans Alone vs. Brain Scans Plus Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer |
Simon Cheng, MD, PhD |
| Lung Cancer |
Study of Combining Osimertinib with and without Ramucirumab in Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Tomivosertib With Anti-PD-(L)1 in Subjects With Non-Small Cell Lung Cancer (NSCLC) |
Brian Henick, MD |
| Lung Cancer |
Study of Osimertinib (TAGRISSOTM) in Non-Small Cell Lung Cancer (NeoADAURA) Patients |
Catherine Shu, MD |
| Lung Cancer |
Study of Atezolizumab and Tiragolumab Alone or in Combination with Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Study in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) whose Disease has Gotten Worse After Osermitinib Treatment |
Catherine Shu, MD |
| Lung Cancer |
Study of Pembrolizumab Alone or in Combination with Chemotherapy in Older Patients with Non-Small Cell Lung Cancer |
Catherine Shu, MD |
| Lung Cancer |
Liver-Directed Radiotherapy Along with Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) and Liver Metastases |
Brian Henick, MD |
| Lung Cancer |
Study of Berzosertib Compared to Chemotherapy for Patients with Non-Small Cell Lung Cancer |
Benjamin Herzberg, MD |
| Lung Cancer |
ApricityCare: Smartphone App Study for Patients with Non-Small Cell Lung Cancer (NSCLC) |
Brian Henick, MD |
| Lung Cancer |
Study of Savolitinib in Combination with Osimertinib vs. Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Study of Patritumab Deruxtecan in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Gynecologic Cancer |
Study of REGN4018 Alone or in Combination with Cemiplimab in Patients with Ovarian Cancer |
June Hou, MD |
| Gynecologic Cancer |
Study of SL-172154 in Combination with PLD or MIRV in Patients with Ovarian Cancer |
June Hou, MD |
| Gynecologic Cancer |
Study of Upifitamab Rilsodotin (XMT-1536) in Patients with Recurrent Ovarian Cancer |
Jason Wright, MD |
| Gynecologic Cancer |
Study of XmAb20717 in Patients with Gynecological Cancer (Cervical, Ovarian, or Endometrial) |
June Hou, MD |
| Gynecologic Cancer |
Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC) |
Jason Wright, MD |
| Gynecologic Cancer |
Comparing Surgeries to Reduce the Risk of Ovarian Cancer in Women with BRCA1 Mutations |
Jason Wright, MD |
| Gynecologic Cancer |
Study of Abemaciclib in Combination with Letrozole in Women with Endometrial Cancer |
Jason Wright, MD |
| Gynecologic Cancer |
Study of MORAb-202 in Women with Ovarian, Fallopian, or Primary Peritoneal Cancer (PPC) |
June Hou, MD |
| Gynecologic Cancer |
Study of ZN-c3 in Patients with Solid Tumors with MRE11, RAD50, NBN, or CCNE1 Gene Mutations |
June Hou, MD |
| Solid Tumors |
Study of Drug Alone and In Combination with Nivolumab in Advanced Solid Tumors |
Brian Henick, MD |
| Solid Tumors |
Study of ASTX295 in Patients With Solid Tumors |
Fabio Iwamoto, MD |
| Solid Tumors |
A Study of XmAb23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) |
Mark Stein, MD |
| Pancreatic Cancer |
The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) |
Fay Kastrinos, MD |
| Pancreatic Cancer |
Study of Multiple Treatment Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery |
Susan Bates, MD |
| Pancreatic Cancer |
Chemo4METPANC: Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Motixafortide, and Cemiplimab in Pancreas Adenocarcinoma |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Registry Study to Evaluate the Nanoknife System in Treating Stage 3 Pancreatic Adenocarcinoma |
Michael Kluger, MD, MPH |
| Pancreatic Cancer |
Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) |
Susan Bates, MD |
| Pancreatic Cancer |
Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer |
Susan Bates, MD |
| Pancreatic Cancer |
Study of Drug - SBP-101 Alone or in Combination with Chemotherapy in Patients with Untreated Pancreatic Ductal Adenocarcinoma (PDAC) |
Gulam Manji, MD, PhD |
| Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
| Leukemia |
Study of Panzyga in Primary Infection Prophylaxis (Prevention) in Patients with Chronic Lymphocytic Leukemia (PRO-SID) |
Nicole Lamanna, MD |
| Leukemia |
Study of BGB-11417 in Patients with Leukemia |
Nicole Lamanna, MD |
| Leukemia |
Study for Patients with Chronic Lymphocytic Leukemia (CLL) who are Currently Receiving Treatment with Venetoclax |
Nicole Lamanna, MD |
| Leukemia |
Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) |
Ran Reshef, MD |
| Leukemia |
Study of Fedratinib in Combination with Chemotherapy in Patients with Myeloproliferative Neoplasm (MPN) in Accelerated and Blast Phase |
Joseph Jurcic, MD |
| Leukemia |
Study of Pirtobrutinib (LOXO-305) Alone or in Combination With Chemotherapy in Patients with Chronic Lymphocytic Leukemia (CLL) |
Nicole Lamanna, MD |
| Leukemia |
Study of Venetoclax and Azacitidine After Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia (AML) |
Ran Reshef, MD |
| Leukemia |
Study of Polatuzumab Vedotin in Combination with Chemotherapy in Subjectswith Richter's Transformation |
Andrew Lipsky, MD |
| Leukemia |
Study of BLU-263 in Patients with Indolent Systemic Mastocytosis (ISM) or Monoclonal Mast Cell Activation Syndrome (mMCAS) |
Joseph Jurcic, MD |
| Leukemia |
Study of Drug - DSP-5336 in Patients with Leukemia |
Joseph Jurcic, MD |
| Leukemia |
Study of Magrolimab in Combination with Chemotherapy in Patients with Acute Myeloid Leukemia (AML) |
Joseph Jurcic, MD |
| Leukemia |
Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia |
Ran Reshef, MD |
| Leukemia |
Study of Etavopivat in Patients with Myelodysplastic Syndromes (MDS) |
Joseph Jurcic, MD |
| Leukemia |
Study of VOR33 in Patients with Acute Myeloid Leukemia (AML) |
Markus Mapara, MD |
| Leukemia |
Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) |
Nobuko Hijiya, MD |
| Leukemia |
Study of SEA-CD70 in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
Joseph Jurcic, MD |
| Bladder Cancer |
ADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the Bladder |
Christopher Anderson, MD |
| Gastrointestinal |
Study of RO7198457 for Patients Who Have Had Surgery for Stage II and Stage III Colon Cancer |
Yoanna Pumpalova, MD |
| Gastrointestinal |
Study of Pembrolizumab Alone or in Combination with Encorafenib and Cetuximab in Patients with Colon Cancer |
Yoanna Pumpalova, MD |
| Gastrointestinal |
Study of Domvanalimab and Zimberelimab Alone or in Combination with Chemotherapy in Patients with Upper Gastrointestinal Cancers (UGI) |
Ryan Moy, MD |
| Gastrointestinal |
Study of DKN-01 in Combination with Tislelizumab & Chemotherapy in Patients with Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer |
Ryan Moy, MD |
| Prostate Cancer |
IRONMAN: International Registry for Men with Advanced Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of ADXS-504 in Patients with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of XmAb20717 Alone or in Combination with Chemotherapy in Patients with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of Cabozantinib in Patients with Prostate Cancer who Previously Received Anti-Androgen Therapy |
Mark Stein, MD |
| Prostate Cancer |
Study of CC-94676 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
Karie D. Runcie, MD |
| Prostate Cancer |
Study of JNJ-78278343 in Patients with Advanced Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of Lutetium-177 PSMA I&T in Patients with Castration-Resistant Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of Whole-Food Plant-Based Diet (WFPBD) to Control Weight in Overweight/Obese Men with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of VTP-850 in Male Patients with Prostate Cancer Whose Prostate-Specific Antigen (PSA) Levels Have Risen |
Mark Stein, MD |
| Kidney Cancer |
Study of Experimental Drug (Axitinib) in Patients with Metastatic Pheochromocytoma (PCC) or Paraganglioma |
Antonio Fojo, MD, PhD |
| Kidney Cancer |
Study of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell Carcinoma |
Karie D. Runcie, MD |
| Kidney Cancer |
Cyto-KIK Trial: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition |
Mark Stein, MD |
| Kidney Cancer |
Study of XmAb819 in Patients with Clear Cell Renal Cell Carcinoma |
Karie D. Runcie, MD |
| Sarcoma |
A Study for Patients with Malignant Peripheral Nerve Sheath Tumors Using Study Drugs PLX3397 and Sirolimus |
Gulam Manji, MD, PhD |
| Sarcoma |
Study of Belinostat and Guadecitabine for Treatment of Chondrosarcoma |
Shaheer Khan, DO |
| Sarcoma |
A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE) |
Prabhjot Mundi, MD |
| Sarcoma |
Study of INBRX 109 in Patients with Metastatic or Inoperable Chondrosarcoma |
Shaheer Khan, DO |
| Sarcoma |
Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma |
Brian Henick, MD |
| Sarcoma |
Study of Drug - CFT8634 in Patients with Synovial Sarcoma or SMARCB1-Null Tumors |
Shaheer Khan, DO |
| Sarcoma |
Study of Unesbulin in Patients with Leiomyosarcoma (LMS) |
Prabhjot Mundi, MD |
| Uveal Melanoma |
A Prospective Natural History Study in Uveal Melanoma |
Shaheer Khan, DO |
| Brain Cancer |
Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM |
Andrew Lassman, MD |
| Brain Cancer |
Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma |
Fabio Iwamoto, MD |
| Brain Cancer |
ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma |
Brian Gill, MD |
| Brain Cancer |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of Vaccine for Cytomegalovirus (CMV) in Patients with Brain Tumors |
Andrew Lassman, MD |
| Brain Cancer |
Study of Focused Ultrasound (FUS) with DEFINITY Microbubbles in Children and Young Adults with Progressive Diffuse Midline Glioma (DMG) |
Cheng-Chia Wu, MD |
| Brain Cancer |
Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of DSP-0390 in Patients with Recurrent High-Grade Glioma |
Mary Welch, MD |
| Brain Cancer |
Study of Safusidenib in Patients with Brain Glioma |
Fabio Iwamoto, MD |
| Brain Tumors |
Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM |
Andrew Lassman, MD |
| Childhood Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
| Brain Tumors |
Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for Treatment of Newly Diagnosed Glioblastoma |
Fabio Iwamoto, MD |
| Squamous Cell Carcinoma |
Study of Ruxolitinib in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma |
Alexander Wei, MD |
| Autoimmune Disorders |
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer |
Brian Henick, MD |
| Brain Tumors |
ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma |
Brian Gill, MD |
| Melanoma |
Study of SD-101 in Patients with Metastatic Uveal Melanoma (Eye Cancer) with Liver Disease |
Alexander Wei, MD |
| Depression |
Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer |
John Markowitz, MD |
| Brain Tumors |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Melanoma |
Study of ALKS 4230 in Patients with Previously Treated Advanced Melanoma |
Benjamin Izar, MD |
| Brain Tumors |
Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) |
Fabio Iwamoto, MD |
| Melanoma |
Study of DYP688 in Patients with Melanoma |
Shaheer Khan, DO |
| Healthy Volunteers |
Columbia University Biobank at New York Presbyterian (CUB-NYP) |
Muredach Reilly, MD |
| Brain Tumors |
Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Brain Tumors |
Study of DSP-0390 in Patients with Recurrent High-Grade Glioma |
Mary Welch, MD |
| Melanoma |
Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma |
Benjamin Izar, MD |
| Endocrine & Metabolic Disease |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
| Diabetes |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
| Healthy Volunteers |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
